+91-22-48913909
ഫിൻ‌കാഷ് »മ്യൂച്വൽ ഫണ്ടുകൾ »മികച്ച പ്രകടനം നടത്തുന്ന ഇക്വിറ്റി ഫണ്ടുകൾ 2018
Table of Contents
2019 ലെ മികച്ച ഇക്വിറ്റി മ്യൂച്വൽ ഫണ്ടുകൾ
ഇക്വിറ്റി ഫണ്ടുകൾ വിവിധ കമ്പനികളുടെ ഇക്വിറ്റി, ഇക്വിറ്റി സംബന്ധിയായ ഉപകരണങ്ങളിൽ നിക്ഷേപിച്ച ഫണ്ട് പണം നിക്ഷേപിക്കുന്നവരാണ്. മിതമായതും ഉയർന്നതുമായ ആളുകൾക്ക് ദീർഘകാല നിക്ഷേപ ഓപ്ഷനായി ഇക്വിറ്റി ഫണ്ടുകൾ കണക്കാക്കപ്പെടുന്നുഅപകടസാധ്യത വിശപ്പ്. ഇക്വിറ്റി ഫണ്ടുകളുടെ വിവിധ വിഭാഗങ്ങൾ ഉൾപ്പെടുന്നുവലിയ ക്യാപ് ഫണ്ടുകൾ,മിഡ് ക്യാപ് ഫണ്ടുകൾ,ചെറിയ ക്യാപ് ഫണ്ടുകൾ,ELSS, ഇത്യാദി. 2019 ൽ, ഇക്വിറ്റി മാർക്കറ്റുകളിൽ ഒരു ഉയർച്ചയുണ്ടായി, ഇക്വിറ്റി ഫണ്ട് വിഭാഗങ്ങളിൽ ഭൂരിഭാഗവും മികച്ച പ്രകടനം കാഴ്ചവച്ചു. ഈ ഫണ്ടുകളുടെ പ്രകടനം വ്യവസായ പ്രകടനം, കമ്പനി പ്രകടനം, കമ്പനികളുടെ വരുമാനവും ലാഭവും, അതിന്റെ ഭാവി സാധ്യതകൾ തുടങ്ങിയ നിരവധി മാക്രോ, മൈക്രോ ഇക്കണോമിക് പാരാമീറ്ററുകളെ ആശ്രയിച്ചിരിക്കുന്നു. മുകളിലുംമികച്ച ഇക്വിറ്റി ഫണ്ടുകൾ 2019 വർഷത്തിൽ ഇനിപ്പറയുന്നവയാണ്.
Talk to our investment specialist
പ്രകടനത്തെ അടിസ്ഥാനമാക്കി 2019 ലെ മികച്ച 10 ഇക്വിറ്റി മ്യൂച്വൽ ഫണ്ടുകൾ
Fund NAV Net Assets (Cr) 2023 (%) 2022 (%) 2021 (%) 2020 (%) 2019 (%) Motilal Oswal Midcap 30 Fund Growth ₹110.575
↓ -2.73 ₹22,898 57.1 41.7 10.7 55.8 9.3 LIC MF Infrastructure Fund Growth ₹50.7595
↓ -1.56 ₹852 47.8 44.4 7.9 46.6 -0.1 Motilal Oswal Long Term Equity Fund Growth ₹54.5438
↓ -1.56 ₹4,187 47.7 37 1.8 32.1 8.8 Motilal Oswal Multicap 35 Fund Growth ₹63.4132
↓ -1.49 ₹12,598 45.7 31 -3 15.3 10.3 Invesco India Mid Cap Fund Growth ₹170.91
↓ -4.01 ₹5,863 43.1 34.1 0.5 43.1 24.4 UTI Healthcare Fund Growth ₹291.379
↓ -2.19 ₹1,203 42.9 38.2 -12.3 19.1 67.4 SBI Healthcare Opportunities Fund Growth ₹440.298
↓ -0.26 ₹3,460 42.2 38.2 -6 20.1 65.8 TATA India Pharma & Healthcare Fund Growth ₹31.4764
↓ -0.33 ₹1,214 40.4 36.6 -8 19.1 64.4 IDBI Small Cap Fund Growth ₹33.579
↓ -1.12 ₹411 40 33.4 2.4 64.7 19 L&T Midcap Fund Growth ₹399.797
↓ -12.62 ₹11,912 39.7 40 1.1 30.4 19 Note: Returns up to 1 year are on absolute basis & more than 1 year are on CAGR basis. as on 6 Jan 25
2019 ലെ മികച്ചതും മികച്ചതുമായ ഇക്വിറ്റി മ്യൂച്വൽ ഫണ്ടുകൾ
(Erstwhile Motilal Oswal MOSt Focused Midcap 30 Fund) The investment objective of the Scheme is to achieve long term capital appreciation by investing in a maximum of 30 quality mid-cap companies having long-term competitive advantages and potential for growth. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Motilal Oswal Midcap 30 Fund is a Equity - Mid Cap fund was launched on 24 Feb 14. It is a fund with Moderately High risk and has given a Below is the key information for Motilal Oswal Midcap 30 Fund Returns up to 1 year are on The investment objective of the scheme is to provide long term growth from a portfolio of equity / equity related instruments of companies engaged either directly or indirectly in the infrastructure sector. LIC MF Infrastructure Fund is a Equity - Sectoral fund was launched on 29 Feb 08. It is a fund with High risk and has given a Below is the key information for LIC MF Infrastructure Fund Returns up to 1 year are on (Erstwhile Motilal Oswal MOSt Focused Long Term Fund) The investment objective of the Scheme is to generate long-term capital appreciation from a diversified portfolio of predominantly equity and equity related instruments. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Motilal Oswal Long Term Equity Fund is a Equity - ELSS fund was launched on 21 Jan 15. It is a fund with Moderately High risk and has given a Below is the key information for Motilal Oswal Long Term Equity Fund Returns up to 1 year are on (Erstwhile Motilal Oswal MOSt Focused Multicap 35 Fund) The investment objective of the Scheme is to achieve long term capital appreciation by primarily investing in a maximum of 35 equity & equity related instruments across sectors and market-capitalization levels.However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved. Motilal Oswal Multicap 35 Fund is a Equity - Multi Cap fund was launched on 28 Apr 14. It is a fund with Moderately High risk and has given a Below is the key information for Motilal Oswal Multicap 35 Fund Returns up to 1 year are on The Scheme seeks to provide long term capital appreciation by investing in a portfolio that is predominantly constituted of equity and equity related instruments of mid cap companies. However, there can be no assurance that the funds objectives will be achieved. Invesco India Mid Cap Fund is a Equity - Mid Cap fund was launched on 19 Apr 07. It is a fund with Moderately High risk and has given a Below is the key information for Invesco India Mid Cap Fund Returns up to 1 year are on (Erstwhile UTI Pharma & Healthcare Fund) The Investment objective of the Scheme is capital appreciation through investments in equities and equity related instruments of the Pharma & Healthcare sectors. UTI Healthcare Fund is a Equity - Sectoral fund was launched on 28 Jun 99. It is a fund with High risk and has given a Below is the key information for UTI Healthcare Fund Returns up to 1 year are on (Erstwhile SBI Pharma Fund) To provide the investors maximum growth opportunity through equity
investments in stocks of growth oriented sectors of the economy. SBI Healthcare Opportunities Fund is a Equity - Sectoral fund was launched on 31 Dec 04. It is a fund with High risk and has given a Below is the key information for SBI Healthcare Opportunities Fund Returns up to 1 year are on The investment objective of the scheme is to seek long term capital appreciation by investing atleast 80% of its net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.However, there is no assurance or guarantee that the investment objective of the Scheme will be achieved.The Scheme does not assure or guarantee any returns. TATA India Pharma & Healthcare Fund is a Equity - Sectoral fund was launched on 28 Dec 15. It is a fund with High risk and has given a Below is the key information for TATA India Pharma & Healthcare Fund Returns up to 1 year are on The Investment objective of the Scheme is to provide investors with the opportunities for long-term capital appreciation by investing predominantly in Equity and Equity related instruments of Small Cap companies. However
there can be no assurance that the investment objective under the Scheme will be realized. IDBI Small Cap Fund is a Equity - Small Cap fund was launched on 21 Jun 17. It is a fund with Moderately High risk and has given a Below is the key information for IDBI Small Cap Fund Returns up to 1 year are on To generate capital appreciation by investing primarily in midcap stocks. The scheme will invest primarily in companies whose market capitalization falls between the highest and the lowest constituent of the Nifty Free Float Midcap 100. L&T Midcap Fund is a Equity - Mid Cap fund was launched on 9 Aug 04. It is a fund with High risk and has given a Below is the key information for L&T Midcap Fund Returns up to 1 year are on 1. Motilal Oswal Midcap 30 Fund
CAGR/Annualized return of 24.8% since its launch. Ranked 27 in Mid Cap category. Return for 2024 was 57.1% , 2023 was 41.7% and 2022 was 10.7% . Motilal Oswal Midcap 30 Fund
Growth Launch Date 24 Feb 14 NAV (06 Jan 25) ₹110.575 ↓ -2.73 (-2.41 %) Net Assets (Cr) ₹22,898 on 30 Nov 24 Category Equity - Mid Cap AMC Motilal Oswal Asset Management Co. Ltd Rating ☆☆☆ Risk Moderately High Expense Ratio 0.66 Sharpe Ratio 2.78 Information Ratio 1.28 Alpha Ratio 24.05 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Dec 19 ₹10,000 31 Dec 20 ₹10,932 31 Dec 21 ₹17,035 31 Dec 22 ₹18,859 31 Dec 23 ₹26,719 31 Dec 24 ₹41,984 Returns for Motilal Oswal Midcap 30 Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 6 Jan 25 Duration Returns 1 Month -1.5% 3 Month 4.5% 6 Month 14% 1 Year 51.1% 3 Year 33.2% 5 Year 33.3% 10 Year 15 Year Since launch 24.8% Historical performance (Yearly) on absolute basis
Year Returns 2023 57.1% 2022 41.7% 2021 10.7% 2020 55.8% 2019 9.3% 2018 9.7% 2017 -12.7% 2016 30.8% 2015 5.2% 2014 16.5% Fund Manager information for Motilal Oswal Midcap 30 Fund
Name Since Tenure Ajay Khandelwal 1 Oct 24 0.25 Yr. Niket Shah 1 Jul 20 4.51 Yr. Santosh Singh 1 Oct 24 0.25 Yr. Rakesh Shetty 22 Nov 22 2.11 Yr. Sunil Sawant 1 Jul 24 0.5 Yr. Data below for Motilal Oswal Midcap 30 Fund as on 30 Nov 24
Equity Sector Allocation
Sector Value Consumer Cyclical 37.33% Technology 24.3% Industrials 20.33% Financial Services 6.71% Health Care 3.21% Basic Materials 3.07% Communication Services 2.24% Real Estate 2.2% Asset Allocation
Asset Class Value Cash 0.61% Equity 99.39% Top Securities Holdings / Portfolio
Name Holding Value Quantity Polycab India Ltd (Industrials)
Equity, Since 30 Sep 23 | POLYCAB10% ₹2,281 Cr 3,125,018
↑ 250,018 Coforge Ltd (Technology)
Equity, Since 31 Mar 23 | COFORGE10% ₹2,258 Cr 2,600,000 Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 29 Feb 24 | KALYANKJIL10% ₹2,210 Cr 30,500,000
↑ 1,516,281 Zomato Ltd (Consumer Cyclical)
Equity, Since 30 Apr 23 | 5433209% ₹2,168 Cr 77,500,000
↑ 45,000,000 Persistent Systems Ltd (Technology)
Equity, Since 31 Jan 23 | PERSISTENT8% ₹1,772 Cr 3,000,000 Mahindra & Mahindra Ltd (Consumer Cyclical)
Equity, Since 31 Oct 24 | M&M6% ₹1,409 Cr 4,750,000
↑ 944,245 Jio Financial Services Ltd (Financial Services)
Equity, Since 31 Aug 23 | JIOFIN6% ₹1,395 Cr 42,500,000
↓ -7,500,000 Trent Ltd (Consumer Cyclical)
Equity, Since 30 Nov 24 | TRENT5% ₹1,189 Cr 1,749,600
↑ 1,749,600 Bajaj Auto Ltd (Consumer Cyclical)
Equity, Since 31 Oct 24 | BAJAJ-AUTO4% ₹1,016 Cr 1,125,000
↓ -242,958 Voltas Ltd (Industrials)
Equity, Since 31 Oct 17 | VOLTAS4% ₹829 Cr 4,999,745
↓ -255 2. LIC MF Infrastructure Fund
CAGR/Annualized return of 10.1% since its launch. Return for 2024 was 47.8% , 2023 was 44.4% and 2022 was 7.9% . LIC MF Infrastructure Fund
Growth Launch Date 29 Feb 08 NAV (06 Jan 25) ₹50.7595 ↓ -1.56 (-2.98 %) Net Assets (Cr) ₹852 on 30 Nov 24 Category Equity - Sectoral AMC LIC Mutual Fund Asset Mgmt Co Ltd Rating Risk High Expense Ratio 2.3 Sharpe Ratio 2.57 Information Ratio 1.04 Alpha Ratio 25.82 Min Investment 5,000 Min SIP Investment 1,000 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Dec 19 ₹10,000 31 Dec 20 ₹9,987 31 Dec 21 ₹14,642 31 Dec 22 ₹15,802 31 Dec 23 ₹22,821 31 Dec 24 ₹33,727 Returns for LIC MF Infrastructure Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 6 Jan 25 Duration Returns 1 Month -3.1% 3 Month 0.1% 6 Month -3.7% 1 Year 44.5% 3 Year 31% 5 Year 27.6% 10 Year 15 Year Since launch 10.1% Historical performance (Yearly) on absolute basis
Year Returns 2023 47.8% 2022 44.4% 2021 7.9% 2020 46.6% 2019 -0.1% 2018 13.3% 2017 -14.6% 2016 42.2% 2015 -2.2% 2014 -6.2% Fund Manager information for LIC MF Infrastructure Fund
Name Since Tenure Yogesh Patil 18 Sep 20 4.29 Yr. Mahesh Bendre 1 Jul 24 0.5 Yr. Data below for LIC MF Infrastructure Fund as on 30 Nov 24
Equity Sector Allocation
Sector Value Industrials 50.6% Basic Materials 11.02% Consumer Cyclical 9.84% Utility 7.43% Financial Services 6.38% Technology 3.93% Real Estate 1.91% Communication Services 1.88% Energy 1.29% Health Care 0.2% Asset Allocation
Asset Class Value Cash 5.52% Equity 94.48% Top Securities Holdings / Portfolio
Name Holding Value Quantity Garware Hi-Tech Films Ltd (Basic Materials)
Equity, Since 31 Aug 23 | 5006555% ₹43 Cr 86,410 Shakti Pumps (India) Ltd (Industrials)
Equity, Since 31 Mar 24 | SHAKTIPUMP4% ₹31 Cr 391,152 REC Ltd (Financial Services)
Equity, Since 31 Jul 23 | RECLTD3% ₹28 Cr 525,720
↑ 92,998 Schneider Electric Infrastructure Ltd (Industrials)
Equity, Since 31 Dec 23 | SCHNEIDER3% ₹27 Cr 328,026 Cummins India Ltd (Industrials)
Equity, Since 31 May 21 | CUMMINSIND3% ₹23 Cr 66,145 ISGEC Heavy Engineering Ltd (Industrials)
Equity, Since 31 Jul 24 | 5330333% ₹21 Cr 149,711 GE Vernova T&D India Ltd (Industrials)
Equity, Since 31 Jan 24 | 5222752% ₹21 Cr 120,063 Bharat Heavy Electricals Ltd (Industrials)
Equity, Since 31 May 24 | BHEL2% ₹21 Cr 838,269 Texmaco Rail & Engineering Ltd (Industrials)
Equity, Since 30 Nov 23 | TEXRAIL2% ₹20 Cr 944,309
↑ 75,376 Bharat Bijlee Ltd (Industrials)
Equity, Since 31 Jul 22 | BBL2% ₹20 Cr 51,606
↑ 4,281 3. Motilal Oswal Long Term Equity Fund
CAGR/Annualized return of 18.6% since its launch. Return for 2024 was 47.7% , 2023 was 37% and 2022 was 1.8% . Motilal Oswal Long Term Equity Fund
Growth Launch Date 21 Jan 15 NAV (06 Jan 25) ₹54.5438 ↓ -1.56 (-2.77 %) Net Assets (Cr) ₹4,187 on 30 Nov 24 Category Equity - ELSS AMC Motilal Oswal Asset Management Co. Ltd Rating Risk Moderately High Expense Ratio 0.74 Sharpe Ratio 3.36 Information Ratio 1.64 Alpha Ratio 21.74 Min Investment 500 Min SIP Investment 500 Exit Load NIL Growth of 10,000 investment over the years.
Date Value 31 Dec 19 ₹10,000 31 Dec 20 ₹10,877 31 Dec 21 ₹14,363 31 Dec 22 ₹14,619 31 Dec 23 ₹20,035 31 Dec 24 ₹29,595 Returns for Motilal Oswal Long Term Equity Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 6 Jan 25 Duration Returns 1 Month -2.7% 3 Month 3.1% 6 Month 10.6% 1 Year 41.4% 3 Year 25.9% 5 Year 24.1% 10 Year 15 Year Since launch 18.6% Historical performance (Yearly) on absolute basis
Year Returns 2023 47.7% 2022 37% 2021 1.8% 2020 32.1% 2019 8.8% 2018 13.2% 2017 -8.7% 2016 44% 2015 12.5% 2014 Fund Manager information for Motilal Oswal Long Term Equity Fund
Name Since Tenure Ajay Khandelwal 11 Dec 23 1.06 Yr. Niket Shah 17 Oct 23 1.21 Yr. Santosh Singh 1 Oct 24 0.25 Yr. Rakesh Shetty 22 Nov 22 2.11 Yr. Data below for Motilal Oswal Long Term Equity Fund as on 30 Nov 24
Equity Sector Allocation
Sector Value Industrials 31.68% Consumer Cyclical 24.69% Financial Services 17.08% Technology 9.32% Real Estate 7.04% Health Care 4.9% Basic Materials 3.86% Asset Allocation
Asset Class Value Cash 1.19% Equity 98.81% Top Securities Holdings / Portfolio
Name Holding Value Quantity Trent Ltd (Consumer Cyclical)
Equity, Since 31 Aug 22 | TRENT7% ₹289 Cr 425,260 Zomato Ltd (Consumer Cyclical)
Equity, Since 31 Oct 23 | 5433207% ₹278 Cr 9,923,692
↓ -779,098 Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 31 Oct 23 | KALYANKJIL5% ₹227 Cr 3,134,622
↓ -162,310 Kaynes Technology India Ltd (Industrials)
Equity, Since 30 Jun 23 | KAYNES4% ₹178 Cr 297,751 Prestige Estates Projects Ltd (Real Estate)
Equity, Since 31 Oct 23 | PRESTIGE4% ₹174 Cr 1,055,205 Gujarat Fluorochemicals Ltd Ordinary Shares (Basic Materials)
Equity, Since 28 Feb 23 | FLUOROCHEM4% ₹162 Cr 408,886 Premier Energies Ltd (Technology)
Equity, Since 30 Sep 24 | PREMIERENE4% ₹155 Cr 1,267,798 Inox Wind Ltd (Industrials)
Equity, Since 31 Dec 23 | INOXWIND4% ₹152 Cr 7,946,960 Suzlon Energy Ltd (Industrials)
Equity, Since 31 Jan 24 | SUZLON4% ₹152 Cr 24,068,813 Apar Industries Ltd (Industrials)
Equity, Since 31 Dec 23 | APARINDS4% ₹150 Cr 148,305 4. Motilal Oswal Multicap 35 Fund
CAGR/Annualized return of 18.9% since its launch. Ranked 5 in Multi Cap category. Return for 2024 was 45.7% , 2023 was 31% and 2022 was -3% . Motilal Oswal Multicap 35 Fund
Growth Launch Date 28 Apr 14 NAV (06 Jan 25) ₹63.4132 ↓ -1.49 (-2.29 %) Net Assets (Cr) ₹12,598 on 30 Nov 24 Category Equity - Multi Cap AMC Motilal Oswal Asset Management Co. Ltd Rating ☆☆☆☆☆ Risk Moderately High Expense Ratio 0.94 Sharpe Ratio 2.6 Information Ratio 0.77 Alpha Ratio 18.56 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Dec 19 ₹10,000 31 Dec 20 ₹11,030 31 Dec 21 ₹12,718 31 Dec 22 ₹12,339 31 Dec 23 ₹16,163 31 Dec 24 ₹23,548 Returns for Motilal Oswal Multicap 35 Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 6 Jan 25 Duration Returns 1 Month -0.8% 3 Month 2.4% 6 Month 11.8% 1 Year 41.9% 3 Year 21.7% 5 Year 19% 10 Year 15 Year Since launch 18.9% Historical performance (Yearly) on absolute basis
Year Returns 2023 45.7% 2022 31% 2021 -3% 2020 15.3% 2019 10.3% 2018 7.9% 2017 -7.8% 2016 43.1% 2015 8.5% 2014 14.6% Fund Manager information for Motilal Oswal Multicap 35 Fund
Name Since Tenure Ajay Khandelwal 1 Oct 24 0.25 Yr. Niket Shah 1 Jul 22 2.51 Yr. Santosh Singh 1 Aug 23 1.42 Yr. Rakesh Shetty 22 Nov 22 2.11 Yr. Atul Mehra 1 Oct 24 0.25 Yr. Sunil Sawant 1 Jul 24 0.5 Yr. Data below for Motilal Oswal Multicap 35 Fund as on 30 Nov 24
Equity Sector Allocation
Sector Value Consumer Cyclical 36.65% Technology 19.23% Industrials 16.8% Financial Services 15.46% Communication Services 8.7% Health Care 1.56% Asset Allocation
Asset Class Value Cash 1.6% Equity 98.4% Top Securities Holdings / Portfolio
Name Holding Value Quantity Polycab India Ltd (Industrials)
Equity, Since 31 Jan 24 | POLYCAB10% ₹1,314 Cr 1,800,000 Kalyan Jewellers India Ltd (Consumer Cyclical)
Equity, Since 30 Sep 23 | KALYANKJIL10% ₹1,250 Cr 17,250,000
↓ -250,000 Coforge Ltd (Technology)
Equity, Since 31 May 23 | COFORGE10% ₹1,242 Cr 1,430,000
↑ 30,000 Trent Ltd (Consumer Cyclical)
Equity, Since 31 Jan 23 | TRENT10% ₹1,226 Cr 1,803,916
↑ 178,916 Persistent Systems Ltd (Technology)
Equity, Since 31 Mar 23 | PERSISTENT9% ₹1,181 Cr 2,000,000
↑ 50,000 Zomato Ltd (Consumer Cyclical)
Equity, Since 30 Apr 23 | 5433209% ₹1,119 Cr 40,000,000
↑ 13,821,974 Jio Financial Services Ltd (Financial Services)
Equity, Since 31 Jul 23 | JIOFIN8% ₹1,067 Cr 32,500,000
↓ -2,500,000 Mahindra & Mahindra Ltd (Consumer Cyclical)
Equity, Since 31 Oct 24 | M&M8% ₹1,023 Cr 3,450,000
↑ 850,000 Bharti Airtel Ltd (Partly Paid Rs.1.25) (Communication Services)
Equity, Since 30 Apr 24 | 8901575% ₹608 Cr 5,000,000 Cholamandalam Investment and Finance Co Ltd (Financial Services)
Equity, Since 31 Mar 23 | CHOLAFIN4% ₹555 Cr 4,500,000 5. Invesco India Mid Cap Fund
CAGR/Annualized return of 17.4% since its launch. Ranked 38 in Mid Cap category. Return for 2024 was 43.1% , 2023 was 34.1% and 2022 was 0.5% . Invesco India Mid Cap Fund
Growth Launch Date 19 Apr 07 NAV (06 Jan 25) ₹170.91 ↓ -4.01 (-2.29 %) Net Assets (Cr) ₹5,863 on 30 Nov 24 Category Equity - Mid Cap AMC Invesco Asset Management (India) Private Ltd Rating ☆☆ Risk Moderately High Expense Ratio 1.89 Sharpe Ratio 2.35 Information Ratio 0 Alpha Ratio 0 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Dec 19 ₹10,000 31 Dec 20 ₹12,438 31 Dec 21 ₹17,803 31 Dec 22 ₹17,895 31 Dec 23 ₹24,001 31 Dec 24 ₹34,358 Returns for Invesco India Mid Cap Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 6 Jan 25 Duration Returns 1 Month -1.9% 3 Month 2.1% 6 Month 8.9% 1 Year 39.5% 3 Year 23.7% 5 Year 28.1% 10 Year 15 Year Since launch 17.4% Historical performance (Yearly) on absolute basis
Year Returns 2023 43.1% 2022 34.1% 2021 0.5% 2020 43.1% 2019 24.4% 2018 3.8% 2017 -5.3% 2016 44.3% 2015 1.1% 2014 6.4% Fund Manager information for Invesco India Mid Cap Fund
Name Since Tenure Aditya Khemani 9 Nov 23 1.15 Yr. Amit Ganatra 1 Sep 23 1.34 Yr. Data below for Invesco India Mid Cap Fund as on 30 Nov 24
Equity Sector Allocation
Sector Value Consumer Cyclical 25.45% Financial Services 18.03% Health Care 14.1% Industrials 13.37% Technology 11% Real Estate 7.62% Basic Materials 5.95% Communication Services 1.29% Asset Allocation
Asset Class Value Cash 0.99% Equity 99.01% Top Securities Holdings / Portfolio
Name Holding Value Quantity The Federal Bank Ltd (Financial Services)
Equity, Since 31 Oct 22 | FEDERALBNK4% ₹264 Cr 12,506,782 Dixon Technologies (India) Ltd (Technology)
Equity, Since 28 Feb 22 | DIXON4% ₹246 Cr 155,335 Trent Ltd (Consumer Cyclical)
Equity, Since 30 Apr 21 | TRENT4% ₹227 Cr 334,743
↑ 22,209 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Dec 22 | MAXHEALTH4% ₹220 Cr 2,246,434 Prestige Estates Projects Ltd (Real Estate)
Equity, Since 30 Nov 23 | PRESTIGE4% ₹216 Cr 1,305,659 Coforge Ltd (Technology)
Equity, Since 31 Mar 22 | COFORGE3% ₹204 Cr 234,918 BSE Ltd (Financial Services)
Equity, Since 31 Dec 23 | BSE3% ₹204 Cr 436,534 L&T Finance Ltd (Financial Services)
Equity, Since 31 Dec 23 | LTF3% ₹192 Cr 13,455,088
↑ 490,532 JK Cement Ltd (Basic Materials)
Equity, Since 31 Oct 22 | JKCEMENT3% ₹161 Cr 376,558 Ethos Ltd (Consumer Cyclical)
Equity, Since 30 Nov 23 | 5435323% ₹157 Cr 479,675 6. UTI Healthcare Fund
CAGR/Annualized return of 15.4% since its launch. Ranked 40 in Sectoral category. Return for 2024 was 42.9% , 2023 was 38.2% and 2022 was -12.3% . UTI Healthcare Fund
Growth Launch Date 28 Jun 99 NAV (06 Jan 25) ₹291.379 ↓ -2.19 (-0.75 %) Net Assets (Cr) ₹1,203 on 30 Nov 24 Category Equity - Sectoral AMC UTI Asset Management Company Ltd Rating ☆ Risk High Expense Ratio 2.38 Sharpe Ratio 2.43 Information Ratio 0.1 Alpha Ratio 0.54 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Dec 19 ₹10,000 31 Dec 20 ₹16,736 31 Dec 21 ₹19,930 31 Dec 22 ₹17,475 31 Dec 23 ₹24,150 31 Dec 24 ₹34,500 Returns for UTI Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 6 Jan 25 Duration Returns 1 Month 0.2% 3 Month 1.5% 6 Month 20.3% 1 Year 37.8% 3 Year 20.5% 5 Year 28.1% 10 Year 15 Year Since launch 15.4% Historical performance (Yearly) on absolute basis
Year Returns 2023 42.9% 2022 38.2% 2021 -12.3% 2020 19.1% 2019 67.4% 2018 1.2% 2017 -7.5% 2016 6.2% 2015 -9.7% 2014 12.4% Fund Manager information for UTI Healthcare Fund
Name Since Tenure Kamal Gada 2 May 22 2.67 Yr. Data below for UTI Healthcare Fund as on 30 Nov 24
Equity Sector Allocation
Sector Value Health Care 96.03% Basic Materials 1.27% Financial Services 0.29% Asset Allocation
Asset Class Value Cash 2.41% Equity 97.59% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Oct 06 | SUNPHARMA11% ₹129 Cr 725,000 Cipla Ltd (Healthcare)
Equity, Since 31 Jan 03 | CIPLA6% ₹69 Cr 450,660 Ajanta Pharma Ltd (Healthcare)
Equity, Since 31 Jul 17 | AJANTPHARM5% ₹58 Cr 193,047
↓ -15,318 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 28 Feb 18 | DRREDDY5% ₹57 Cr 470,234
↑ 34,734 Glenmark Pharmaceuticals Ltd (Healthcare)
Equity, Since 31 Mar 24 | GLENMARK4% ₹47 Cr 309,311
↑ 58,980 Gland Pharma Ltd (Healthcare)
Equity, Since 30 Nov 20 | GLAND4% ₹46 Cr 266,306 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 30 Apr 21 | APOLLOHOSP3% ₹41 Cr 60,000 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Dec 20 | FORTIS3% ₹40 Cr 611,658
↓ -22,787 Procter & Gamble Health Ltd (Healthcare)
Equity, Since 31 Dec 20 | PGHL3% ₹38 Cr 74,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB3% ₹38 Cr 61,480 7. SBI Healthcare Opportunities Fund
CAGR/Annualized return of 16.1% since its launch. Ranked 34 in Sectoral category. Return for 2024 was 42.2% , 2023 was 38.2% and 2022 was -6% . SBI Healthcare Opportunities Fund
Growth Launch Date 31 Dec 04 NAV (03 Jan 25) ₹440.298 ↓ -0.26 (-0.06 %) Net Assets (Cr) ₹3,460 on 30 Nov 24 Category Equity - Sectoral AMC SBI Funds Management Private Limited Rating ☆☆ Risk High Expense Ratio 2.09 Sharpe Ratio 2.85 Information Ratio 0.75 Alpha Ratio 5.08 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-15 Days (0.5%),15 Days and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Dec 19 ₹10,000 31 Dec 20 ₹16,583 31 Dec 21 ₹19,925 31 Dec 22 ₹18,725 31 Dec 23 ₹25,885 31 Dec 24 ₹36,814 Returns for SBI Healthcare Opportunities Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 6 Jan 25 Duration Returns 1 Month 2.6% 3 Month 5.6% 6 Month 22.4% 1 Year 39.5% 3 Year 23.1% 5 Year 29.7% 10 Year 15 Year Since launch 16.1% Historical performance (Yearly) on absolute basis
Year Returns 2023 42.2% 2022 38.2% 2021 -6% 2020 20.1% 2019 65.8% 2018 -0.5% 2017 -9.9% 2016 2.1% 2015 -14% 2014 27.1% Fund Manager information for SBI Healthcare Opportunities Fund
Name Since Tenure Tanmaya Desai 1 Jun 11 13.6 Yr. Pradeep Kesavan 31 Dec 23 1.01 Yr. Data below for SBI Healthcare Opportunities Fund as on 30 Nov 24
Equity Sector Allocation
Sector Value Health Care 89.92% Basic Materials 6.58% Asset Allocation
Asset Class Value Cash 3.5% Equity 96.5% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Dec 17 | SUNPHARMA13% ₹445 Cr 2,500,000
↑ 100,000 Divi's Laboratories Ltd (Healthcare)
Equity, Since 31 Mar 12 | DIVISLAB6% ₹222 Cr 360,000 Cipla Ltd (Healthcare)
Equity, Since 31 Aug 16 | CIPLA6% ₹196 Cr 1,280,000
↑ 280,000 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Mar 21 | MAXHEALTH6% ₹196 Cr 2,000,000
↓ -100,000 Lupin Ltd (Healthcare)
Equity, Since 31 Aug 23 | LUPIN5% ₹164 Cr 800,000 Lonza Group Ltd ADR (Healthcare)
Equity, Since 31 Jan 24 | LZAGY4% ₹152 Cr 300,000 Poly Medicure Ltd (Healthcare)
Equity, Since 31 Aug 24 | POLYMED4% ₹139 Cr 500,000
↓ -140,000 Krishna Institute of Medical Sciences Ltd (Healthcare)
Equity, Since 30 Nov 22 | 5433084% ₹130 Cr 2,200,000
↓ -300,000 Jupiter Life Line Hospitals Ltd (Healthcare)
Equity, Since 31 Aug 23 | JLHL4% ₹126 Cr 832,871
↓ -67,129 Aether Industries Ltd (Basic Materials)
Equity, Since 31 May 22 | 5435343% ₹115 Cr 1,400,000 8. TATA India Pharma & Healthcare Fund
CAGR/Annualized return of 13.5% since its launch. Return for 2024 was 40.4% , 2023 was 36.6% and 2022 was -8% . TATA India Pharma & Healthcare Fund
Growth Launch Date 28 Dec 15 NAV (06 Jan 25) ₹31.4764 ↓ -0.33 (-1.03 %) Net Assets (Cr) ₹1,214 on 30 Nov 24 Category Equity - Sectoral AMC Tata Asset Management Limited Rating Risk High Expense Ratio 0 Sharpe Ratio 2.17 Information Ratio 0.55 Alpha Ratio 4.58 Min Investment 5,000 Min SIP Investment 150 Exit Load 0-3 Months (0.25%),3 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Dec 19 ₹10,000 31 Dec 20 ₹16,438 31 Dec 21 ₹19,572 31 Dec 22 ₹17,998 31 Dec 23 ₹24,582 31 Dec 24 ₹34,513 Returns for TATA India Pharma & Healthcare Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 6 Jan 25 Duration Returns 1 Month 2.2% 3 Month 2.1% 6 Month 15.8% 1 Year 35.2% 3 Year 21.1% 5 Year 27.9% 10 Year 15 Year Since launch 13.5% Historical performance (Yearly) on absolute basis
Year Returns 2023 40.4% 2022 36.6% 2021 -8% 2020 19.1% 2019 64.4% 2018 5.5% 2017 -2.6% 2016 4.7% 2015 -14.7% 2014 Fund Manager information for TATA India Pharma & Healthcare Fund
Name Since Tenure Meeta Shetty 9 Mar 21 3.82 Yr. Rajat Srivastava 16 Sep 24 0.29 Yr. Data below for TATA India Pharma & Healthcare Fund as on 30 Nov 24
Equity Sector Allocation
Sector Value Health Care 93.55% Basic Materials 2.17% Asset Allocation
Asset Class Value Cash 4.28% Equity 95.72% Top Securities Holdings / Portfolio
Name Holding Value Quantity Sun Pharmaceuticals Industries Ltd (Healthcare)
Equity, Since 31 Jan 16 | SUNPHARMA12% ₹143 Cr 804,300 Aurobindo Pharma Ltd (Healthcare)
Equity, Since 30 Apr 20 | AUROPHARMA8% ₹94 Cr 741,000 Lupin Ltd (Healthcare)
Equity, Since 30 Nov 17 | LUPIN7% ₹84 Cr 410,240 Cipla Ltd (Healthcare)
Equity, Since 30 Apr 20 | CIPLA6% ₹75 Cr 490,000 Dr Reddy's Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 18 | DRREDDY6% ₹74 Cr 614,555 Divi's Laboratories Ltd (Healthcare)
Equity, Since 30 Sep 17 | DIVISLAB5% ₹65 Cr 104,965 Fortis Healthcare Ltd (Healthcare)
Equity, Since 31 Oct 20 | FORTIS5% ₹56 Cr 855,100 Zydus Lifesciences Ltd (Healthcare)
Equity, Since 31 Dec 22 | ZYDUSLIFE4% ₹46 Cr 471,287 Alkem Laboratories Ltd (Healthcare)
Equity, Since 31 Aug 20 | ALKEM3% ₹42 Cr 75,249 Apollo Hospitals Enterprise Ltd (Healthcare)
Equity, Since 31 Dec 16 | APOLLOHOSP3% ₹40 Cr 58,903 9. IDBI Small Cap Fund
CAGR/Annualized return of 17.4% since its launch. Return for 2024 was 40% , 2023 was 33.4% and 2022 was 2.4% . IDBI Small Cap Fund
Growth Launch Date 21 Jun 17 NAV (06 Jan 25) ₹33.579 ↓ -1.12 (-3.24 %) Net Assets (Cr) ₹411 on 30 Nov 24 Category Equity - Small Cap AMC IDBI Asset Management Limited Rating Risk Moderately High Expense Ratio 2.3 Sharpe Ratio 2.03 Information Ratio 0.03 Alpha Ratio 10.9 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-12 Months (1%),12 Months and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Dec 19 ₹10,000 31 Dec 20 ₹11,896 31 Dec 21 ₹19,592 31 Dec 22 ₹20,066 31 Dec 23 ₹26,769 31 Dec 24 ₹37,480 Returns for IDBI Small Cap Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 6 Jan 25 Duration Returns 1 Month -2.6% 3 Month 1.1% 6 Month 1.7% 1 Year 35.6% 3 Year 22.9% 5 Year 30.2% 10 Year 15 Year Since launch 17.4% Historical performance (Yearly) on absolute basis
Year Returns 2023 40% 2022 33.4% 2021 2.4% 2020 64.7% 2019 19% 2018 -4.4% 2017 -15% 2016 2015 2014 Fund Manager information for IDBI Small Cap Fund
Name Since Tenure Nikhil Rungta 1 Jul 24 0.5 Yr. Mahesh Bendre 1 Jul 24 0.5 Yr. Data below for IDBI Small Cap Fund as on 30 Nov 24
Equity Sector Allocation
Sector Value Industrials 34.87% Consumer Cyclical 15.44% Basic Materials 14.33% Utility 7.2% Consumer Defensive 6.79% Health Care 5.43% Financial Services 4.84% Technology 4.29% Communication Services 2.98% Real Estate 1.44% Asset Allocation
Asset Class Value Cash 2.39% Equity 97.61% Top Securities Holdings / Portfolio
Name Holding Value Quantity JTL Industries Ltd (Basic Materials)
Equity, Since 31 Jul 24 | 5346003% ₹13 Cr 1,263,574
↑ 291,276 Shakti Pumps (India) Ltd (Industrials)
Equity, Since 31 Mar 24 | SHAKTIPUMP3% ₹11 Cr 142,830
↓ -8,310 Kilburn Engineering Ltd (Industrials)
Equity, Since 30 Nov 24 | 5221013% ₹11 Cr 215,000
↑ 215,000 Himatsingka Seide Ltd (Consumer Cyclical)
Equity, Since 31 Oct 24 | HIMATSEIDE2% ₹10 Cr 545,700 TD Power Systems Ltd (Industrials)
Equity, Since 31 Aug 23 | TDPOWERSYS2% ₹10 Cr 224,441 Artemis Medicare Services Ltd Ordinary Shares (Healthcare)
Equity, Since 31 Oct 23 | 5429192% ₹10 Cr 296,517 Kirloskar Oil Engines Ltd (Industrials)
Equity, Since 28 Feb 21 | KIRLOSENG2% ₹10 Cr 86,263 Piramal Pharma Ltd (Healthcare)
Equity, Since 30 Sep 23 | PPLPHARMA2% ₹10 Cr 358,586 Garware Hi-Tech Films Ltd (Basic Materials)
Equity, Since 31 Aug 23 | 5006552% ₹10 Cr 19,459
↓ -8,280 Hi-Tech Pipes Ltd (Basic Materials)
Equity, Since 31 Oct 24 | HITECH2% ₹10 Cr 582,210 10. L&T Midcap Fund
CAGR/Annualized return of 19.8% since its launch. Ranked 5 in Mid Cap category. Return for 2024 was 39.7% , 2023 was 40% and 2022 was 1.1% . L&T Midcap Fund
Growth Launch Date 9 Aug 04 NAV (06 Jan 25) ₹399.797 ↓ -12.62 (-3.06 %) Net Assets (Cr) ₹11,912 on 30 Nov 24 Category Equity - Mid Cap AMC L&T Investment Management Ltd Rating ☆☆☆☆ Risk High Expense Ratio 1.77 Sharpe Ratio 2.6 Information Ratio 0.14 Alpha Ratio 12.22 Min Investment 5,000 Min SIP Investment 500 Exit Load 0-1 Years (1%),1 Years and above(NIL) Growth of 10,000 investment over the years.
Date Value 31 Dec 19 ₹10,000 31 Dec 20 ₹11,905 31 Dec 21 ₹15,523 31 Dec 22 ₹15,689 31 Dec 23 ₹21,966 31 Dec 24 ₹30,693 Returns for L&T Midcap Fund
absolute basis & more than 1 year are on CAGR (Compound Annual Growth Rate) basis. as on 6 Jan 25 Duration Returns 1 Month -2.9% 3 Month 1.3% 6 Month 4.4% 1 Year 34.9% 3 Year 24.2% 5 Year 24.9% 10 Year 15 Year Since launch 19.8% Historical performance (Yearly) on absolute basis
Year Returns 2023 39.7% 2022 40% 2021 1.1% 2020 30.4% 2019 19% 2018 -0.2% 2017 -12% 2016 52.3% 2015 9.8% 2014 10.8% Fund Manager information for L&T Midcap Fund
Name Since Tenure Venugopal Manghat 1 Oct 23 1.25 Yr. Cheenu Gupta 26 Nov 22 2.1 Yr. Sonal Gupta 1 Oct 23 1.25 Yr. Data below for L&T Midcap Fund as on 30 Nov 24
Equity Sector Allocation
Sector Value Industrials 33.1% Financial Services 18.31% Consumer Cyclical 12.49% Technology 11.5% Real Estate 6.6% Health Care 6.49% Utility 4.94% Consumer Defensive 2.13% Basic Materials 1.6% Communication Services 0.05% Asset Allocation
Asset Class Value Cash 1.67% Equity 98.33% Top Securities Holdings / Portfolio
Name Holding Value Quantity Suzlon Energy Ltd (Industrials)
Equity, Since 31 Mar 24 | SUZLON5% ₹569 Cr 90,407,100 CG Power & Industrial Solutions Ltd (Industrials)
Equity, Since 31 May 24 | CGPOWER5% ₹552 Cr 7,543,500
↑ 321,500 Dixon Technologies (India) Ltd (Technology)
Equity, Since 30 Apr 24 | DIXON4% ₹482 Cr 304,800 PB Fintech Ltd (Financial Services)
Equity, Since 31 Jan 24 | 5433904% ₹445 Cr 2,351,700 Trent Ltd (Consumer Cyclical)
Equity, Since 30 Jun 19 | TRENT4% ₹431 Cr 634,900 Zomato Ltd (Consumer Cyclical)
Equity, Since 31 Mar 24 | 5433204% ₹423 Cr 15,135,559
↑ 459,759 JSW Energy Ltd (Utilities)
Equity, Since 31 Mar 24 | JSWENERGY3% ₹412 Cr 6,288,700 HDFC Asset Management Co Ltd (Financial Services)
Equity, Since 31 Dec 22 | HDFCAMC3% ₹405 Cr 964,400 Cummins India Ltd (Industrials)
Equity, Since 30 Apr 18 | CUMMINSIND3% ₹338 Cr 970,100 Max Healthcare Institute Ltd Ordinary Shares (Healthcare)
Equity, Since 30 Sep 21 | MAXHEALTH3% ₹328 Cr 3,343,000
↑ 472,900
ഇവിടെ നൽകിയിരിക്കുന്ന വിവരങ്ങൾ കൃത്യമാണെന്ന് ഉറപ്പാക്കാൻ എല്ലാ ശ്രമങ്ങളും നടത്തി. എന്നിരുന്നാലും, ഡാറ്റയുടെ കൃത്യത സംബന്ധിച്ച് ഒരു ഉറപ്പുമില്ല. നിക്ഷേപം നടത്തുന്നതിന് മുമ്പ് ദയവായി സ്കീം വിവര പ്രമാണം ഉപയോഗിച്ച് പരിശോധിക്കുക.
AMFI Registration No. 112358 | CIN: U74999MH2016PTC282153
Shepard Technologies Pvt. Ltd. (with ARN code 112358) makes no warranties or representations, express or implied, on products offered through the platform. It accepts no liability for any damages or losses, however caused, in connection with the use of, or on the reliance of its product or related services. Terms and conditions of the website are applicable.
©2025 Shepard Technologies Private Limited. All Rights Reserved